Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

181.19 -1.72 (-0.94%)
Streaming Delayed Price Updated: 2:41 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Quest Diagnostics: A Solid Investment or a Risky Bet?
Join us as we analyze Quest Diagnostics and uncover whether this lab giant is a smart investment choice for the future. With insights from industry experts, you won't want to miss this evaluation! 
Via The Motley Fool
Q2 Earnings Highs And Lows: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting... 
Via StockStory
This Quest Diagnostics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
 
Via Benzinga
A Glimpse Into The Expert Outlook On Quest Diagnostics Through 5 Analysts
 
Via Benzinga
Quest Diagnostics Earnings Preview
 
Via Benzinga
Where Quest Diagnostics Stands With Analysts
 
Via Benzinga
What Does the Market Think About Quest Diagnostics?
 
Via Benzinga
3 S&P 500 Stocks That Concern Us
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Malware Stocks
Options Corner: Quest Diagnostics' Post-Earnings Digestion Drama Opens A Science-Backed Opportunity
Quest Diagnostics delivered better-than-expected Q2 earnings results, yet DGX stock stumbled, which opens a contrarian opportunity. 
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 15.2% year on year to $2.76 billion. The company’s... 
Via StockStory
Topics World Trade
Quest Diagnostics Raises 2025 Guidance
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
Looking Into Quest Diagnostics's Recent Short Interest
 
Via Benzinga
Quest Diagnostics Boosts Its 2025 Outlook
Via The Motley Fool
Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks
Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid operating margins. 
Via Benzinga
Unusual volume S&P500 stocks in Tuesday's session
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Discover which S&P500 stocks are making waves on Tuesday.
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?
It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings. 
Via Benzinga
Why Quest (DGX) Stock Is Up Today
Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.4% in the morning session after the company reported strong second-quarter financial results that beat Wall Street... 
Via StockStory
Quest (DGX) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Quest (NYSE:DGX) Surprises With Q2 Sales
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q2 CY2025, with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue... 
Via StockStory
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Quest (DGX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings this Tuesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
Earnings Scheduled For July 22, 2025
 
Via Benzinga
QUEST DIAGNOSTICS INC (NYSE:DGX) - A Reliable Dividend Stock With Strong Fundamentals
QUEST DIAGNOSTICS INC (NYSE:DGX) offers a reliable dividend with steady growth, strong profitability, and sound financial health, making it a compelling choice for income investors. 
Via Chartmill
1 Mid-Cap Stock with Competitive Advantages and 2 to Brush Off
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Motley Fool Investors Look Back at the First Half of 2025
Via The Motley Fool
Topics Government World Trade
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.